Salarius Pharmaceuticals, Inc. (SLRX)
Salarius Pharmaceuticals, Inc. is a clinical-stage oncology company, which engages in the development of treatments for cancers with high, unmet medical need. Its pipeline includes SP-3164, a targeted protein degrader and seclidemstat (SP-2577), a targeted protein inhibitor. The company was founded in February 2014 and is headquartered in Houston, TX.
Address
2450 HOLCOMBE BLVD
HOUSTON, TX 77021
Founded
2014
Number of Employees
2
Website
http://salariuspharma.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)
Never miss an email alert when insiders at SLRX make a trade.
Creating a free account takes less than one minute